Next »
Clinical Microbiology Newsletter
Volume 32, Issue 2
, Pages 9-15
, 15 January 2010
The Best Practices for Screening, Monitoring, and Diagnosis of Cytomegalovirus Disease, Part II
References
- . Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection . Rev. Med. Virol. . 2007;17:253–276
-
Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality
.
Pediatr. Infect. Dis.
. 1992;11:93–99
- The outcome of congenital cytomegalovirus in relation to maternal antibody status . N. Engl. J. Med. . 1992;326:663–667
- Increased risk of cytomegalovirus transmission in utero during late gestation . Obstet. Gynecol. . 1999;93:658–660
- Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome . J. Clin. Virol. . 2006;35:216–220
- . Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant . Clin. Microbiol. Rev. . 2002;15:680–715
- Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus . J. Am. Acad. Audiol. . 2000;11:283–290
- Histological findings in foetuses congenitally infected by cytomegalovirus . J. Clin. Virol. . 2009;46(Suppl. 4):S16–S21
- Guidelines on CMV congenital infection . J. Perinat. Med. . 2009;37:433–445
- Prevention of child-to-mother transmission of cytomegalovirus among pregnant women . J. Pediatr. . 2004;145:485–491
- New advances in the diagnosis of congenital cytomegalo virus infection . J. Clin. Virol. . 2008;41:192–197
- A serological testing algorithm for the diagnosis of primary CMV infection in pregnant women . Prenat. Diagn. . 2004;24:861–863
- Maternal IgG avidity and IgM detected by blot as diagnostic tools to identify pregnant women at risk of transmitting cytomegalovirus . Viral Immunol. . 2000;13:137–141
- Development of human cytomegalovirus-specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus . J. Infect. Dis. . 2007;195:1062–1070
- Impact of diagnostic and confirmatory tests and prenatal counseling on the rate of pregnancy termination among women with positive cytomegalovirus immunoglobulin M antibody titers . Am. J. Obstet. Gynecol. . 2007;196:221.e1–221.e6
-
The prognostic value of ultrasound abnormalities and biological parameters in blood of fetuses infected with cytomegalovirus
.
Br. J. Obstet. Gynecol.
. 2008;115:823–829
- A classification of pregnancy losses after invasive prenatal diagnostic procedures: an approach to allow comparison of units with a different case mix . Prenat. Diagn. . 2003;23:488–492
- Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome . Prenat. Diagn. . 2001;21:362–377
-
Lazzarotto, T. et al. 2009. Prenatal diagnosis of congenital cytomegalovirus (CMV) infection and outcome in 598 pregnant women undergoing a primary CMV infection. OR 10.2. In Abstracts of the 12th International CMV/BetaHerpesvirus Workshop, 10-14 May 2009, Boston, MA.
- Neonatal cytomegalovirus blood load and risk of sequele in symptomatic and asymptomatic congenitally infected newborns . Pediatrics . 2006;117:e76–e83
- Diagnosis of congenital CMV infection via dried blood spots . Rev. Med. Virol. . 2006;16:385–392
-
.
Newborn CMV screening: NIDCD CHIMES Study. Congenital Cytomegalovirus Conference 2008, Atlanta, GA, 5-7 November 2008
.
http://www.congenitalcmv.org.htm
- Cytomegalovirus shedding and delayed sensorineural hearing loss: results from longitudinal follow-up of children with congenital infection . Pediatr. Infect. Dis. J. . 2009;28:515–520
- Passive immunization during pregnancy for congenital cytomegalovirus infection . N. Engl. J. Med. . 2005;353:1350–1362
-
Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection
.
Br. J. Obstet. Gynecol.
. 2007;114:1113–1121
- Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial . J. Pediatr. . 2003;143:16–25
- Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease . J. Infect. Dis. . 2008;197:836–845
- Vaccine prevention of maternal cytomegalovirus infection . N. Engl. J. Med. . 2009;360:1191–1199
Editor's Note: Part I of this article was published in the January 1, 2010 issue of CMN (Vol. 32, No. 1).
PII: S0196-4399(09)00062-2
doi: 10.1016/j.clinmicnews.2009.12.004
© 2010 Elsevier Inc. All rights reserved.
Next »
Clinical Microbiology Newsletter
Volume 32, Issue 2
, Pages 9-15
, 15 January 2010
